0610007L01Rik Activators comprise a diverse array of chemical compounds that serve to enhance the functional activity of 0610007L01Rik through various direct and indirect mechanisms within cellular signaling networks. For instance, the elevation of intracellular cAMP by Forskolin, and the prevention of cAMP breakdown by IBMX, both lead to the activation of PKA. Activated PKA then enhances the activity of 0610007L01Rik through phosphorylation of its associated proteins. Similarly, PMA activates PKC, which phosphorylates and enhances the activity of 0610007L01Rik. Sphingosine-1-phosphate engages its receptors to initiate downstream signaling events, thereby indirectly enhancing 0610007L01Rik activity. Anisomycin, a JNK pathway activator, and Thapsigargin, which raises cytosolic calcium levels, both modulate the activityof 0610007L01Rik via their respective signaling pathways, leading to its enhanced functional state. Furthermore, the inhibitory action of Epigallocatechin gallate on certain kinases can lift the repression on 0610007L01Rik, potentially increasing its activity. LY294002, through PI3K inhibition, and U0126, by inhibiting MEK, can alter signaling dynamics in a way that compensatively activates alternative pathways, thus enhancing the activity of 0610007L01Rik.
The modulatory effects of these compounds on various kinases and phosphatases create a conducive environment for the activation of 0610007L01Rik. Adding to the complexity of 0610007L01Rik regulation, A23187, by acting as a calcium ionophore, increases intracellular calcium levels, thereby activating calcium-dependent signaling pathways which indirectly enhance the functional activity of 0610007L01Rik. Staurosporine, despite its broad kinase inhibitory spectrum, may preferentially inhibit kinases that negatively regulate 0610007L01Rik, resulting in its enhanced activity. Lastly, Genistein's inhibition of tyrosine kinases reduces competitive phosphorylation events, allowing for greater activity of pathways in which 0610007L01Rik is involved. Collectively, these activators strategically manipulate cellular signaling to augment the activity of 0610007L01Rik without the need for upregulating its expression or directly interacting with the protein, highlighting their unique and specific roles in modulating 0610007L01Rik's functionality within cells.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. The increased levels of cAMP activate PKA, which then enhances the activity of 0610007L01Rik through phosphorylation of associated proteins. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate 0610007L01Rik or its interacting proteins, enhancing 0610007L01Rik's activity in signaling pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can lead to downstream signaling events that enhance the activity of 0610007L01Rik through protein-protein interactions. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin acts as a JNK activator. The JNK pathway can phosphorylate substrates that modulate the activity of 0610007L01Rik, resulting in its functional enhancement. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin induces an increase in cytosolic calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). Elevated calcium can activate calmodulin-dependent kinases, which in turn can enhance the activity of 0610007L01Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin gallate inhibits certain kinases, which may relieve negative regulatory constraints on 0610007L01Rik, thus enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter downstream signaling pathways, leading to the activation of proteins that enhance the activity of 0610007L01Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is a MEK inhibitor that can shift signaling dynamics, potentially leading to the activation of alternative pathways that enhance the activity of 0610007L01Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, which activates calcium-dependent signaling pathways, indirectly enhancing the functional activity of 0610007L01Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. By selectively inhibiting kinases that suppress 0610007L01Rik's activity, it can indirectly enhance 0610007L01Rik function. | ||||||